DOI QR코드

DOI QR Code

Evaluation of the Combination of Methylprednisolone and Tranilast after Spinal Cord Injury in Rat Models

  • Mbori, Ngwayi James Reeves (Department of Orthopedic Surgery (Unit III), First Affiliated Hospital of Jiamusi University, Heilongjiang Province) ;
  • Chuan, Xie Yun (Department of Orthopedic Surgery (Unit III), First Affiliated Hospital of Jiamusi University, Heilongjiang Province) ;
  • Feng, Qiao Xiao (Department of Orthopedic Surgery (Unit III), First Affiliated Hospital of Jiamusi University, Heilongjiang Province) ;
  • Alizada, Mujahid (Department of Neurosurgery, First Affiliated Hospital of Jiamusi University, Heilongjiang Province) ;
  • Zhan, Jing (Department of Orthopedic Surgery (Unit III), First Affiliated Hospital of Jiamusi University, Heilongjiang Province)
  • Received : 2015.11.17
  • Accepted : 2016.03.28
  • Published : 2016.07.01

Abstract

Objective : The aim of our study was to evaluate the neuroprotective functions of the combination therapy using methylprednisolone (MP) and tranilast (TR) after spinal cord injury (SCI) in adult rats. Methods : Spinal cord compression injury model was achieved using Yasargil aneurysm clip. Rats were divided into control group, MP group, TR group, and combination therapy group using TR and MP. Rat models were assessed for locomotor functional recovery using Basso, Beattie, and Bresnahan (BBB) score, spinal cord water content and myeloperoxidase (MPO) activity 24 hours post SCI, haematoxylin and eosin staining and glial fibrillary acid protein (GFAP) staining at 7 and 14 days post SCI. Results : The spinal cord water content and MPO activity in the combination therapy group was significantly lower than the control group and the individual therapy groups p<0.05. The combination therapy group had significantly higher BBB scores than control group and individual therapy groups (p<0.05). At one week after SCI, GFAP expression in the combination group was significantly lower than the control group (p<0.05) but there was no significant difference compared to the individual therapy groups (p>0.05). At 2 weeks after SCI there was a slight decrease in GFAP expression compared to the first week but the difference was not statistically significant (p>0.05), GFAP expression between the groups was not statistically significant p>0.05. Conclusion : Combining MP and TR is therapeutically more effective in improving functional recovery, inhibiting inflammation and glial scar formation after acute SCI.

Keywords

References

  1. Alovskaya A, Alekseeva T, Phillips JB, King V, Brown R : Fibronectin, collagen, fibrin components of extracellular matrix for nerve regeneration in Ashammakhi N, Reis RL, Chiellini E (eds) : Topics in Tissue Engineering, Chapter 12. Expertissues (ebook), 2007, Vol 3. Available from : http://oro.open.ac.uk/9064/
  2. Basso DM, Beattie MS, Bresnahan JC : A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12 : 1-21, 1995 https://doi.org/10.1089/neu.1995.12.1
  3. Bracken MB : Pharmacological interventions for acute spinal cord injury. Cochrane Database Syst Rev (2) : CD001046, 2000
  4. Bradbury EJ, McMahon SB : Spinal cord repair strategies : why do they work? Nat Rev Neurosci 7 : 644-653, 2006 https://doi.org/10.1038/nrn1964
  5. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, et al. : Acute spinal cord injury, part I : pathophysiologic mechanisms. Clin Neuropharmacol 24 : 254-264, 2001 https://doi.org/10.1097/00002826-200109000-00002
  6. Gerndt SJ, Rodriguez JL, Pawlik JW, Taheri PA, Wahl WL, Micheals AJ, et al. : Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma 42 : 279-284, 1997 https://doi.org/10.1097/00005373-199702000-00017
  7. Grimpe B, Silver J : A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord. J Neurosci 24 : 1393-1397, 2004 https://doi.org/10.1523/JNEUROSCI.4986-03.2004
  8. Hanada M, Tsutsumi K, Arima H, Shinjo R, Sugiura Y, Imagama S, et al. : Evaluation of the effect of tranilast on rats with spinal cord injury. J Neurol Sci 346 : 209-215, 2014 https://doi.org/10.1016/j.jns.2014.08.028
  9. Hsu CY, Dimitrijevic MR : Methylprednisolone in spinal cord injury : the possible mechanism of action. J Neurotrauma 7 : 115-119, 1990 https://doi.org/10.1089/neu.1990.7.115
  10. Jazayeri SB, Firouzi M, Abdollah Zadegan S, Saeedi N, Pirouz E, Nategh M, et al. : The effect of timing of decompression on neurologic recovery and histopathologic findings after spinal cord compression in a rat model. Acta Med Iran 51 : 431-437, 2013
  11. Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, et al. : Small-molecule-induced Rho-inhibition : NSAIDs after spinal cord injury. Cell Tissue Res 349 : 119-132, 2012 https://doi.org/10.1007/s00441-012-1334-7
  12. Lagord C, Berry M, Logan A : Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 20 : 69-92, 2002 https://doi.org/10.1006/mcne.2002.1121
  13. Lee BH, Lee KH, Yoon DH, Kim UJ, Hwang YS, Park SK, et al. : Effects of methylprednisolone on the neural conduction of the motor evoked potentials in spinal cord injured rats. J Korean Med Sci 20 : 132-138, 2005 https://doi.org/10.3346/jkms.2005.20.1.132
  14. Li Z, DU J, Sun H, Mang J, He J, Wang J, et al. : Effects of the combination of methylprednisolone with aminoguanidine on functional recovery in rats following spinal cord injury. Exp Ther Med 7 : 1605-1610, 2014 https://doi.org/10.3892/etm.2014.1613
  15. Liu WL, Lee YH, Tsai SY, Hsu CY, Sun YY, Yang LY, et al. : Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes. Glia 56 : 1390-1400, 2008 https://doi.org/10.1002/glia.20706
  16. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H : Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976) 26 : 426-430, 2001 https://doi.org/10.1097/00007632-200102150-00020
  17. Messina S, Bitto A, Aguennouz M, Mazzeo A, Migliorato A, Polito F, et al. : Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice : a comparison study with methylprednisolone. Exp Neurol 220 : 349-358, 2009 https://doi.org/10.1016/j.expneurol.2009.09.015
  18. Miyazawa K, Hamano S, Ujiie A : Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. Br J Pharmacol 118 : 915-922, 1996 https://doi.org/10.1111/j.1476-5381.1996.tb15486.x
  19. Moon LD, Fawcett JW : Reduction in CNS scar formation without concomitant increase in axon regeneration following treatment of adult rat brain with a combination of antibodies to TGFbeta1 and beta2. Eur J Neurosci 14 : 1667-1677, 2001 https://doi.org/10.1046/j.0953-816x.2001.01795.x
  20. Mullane K : Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 301 : 39-51, 1989
  21. Nakazawa M, Yoshimura T, Naito J, Azuma H : [Pharmacological properties of N-(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5'), a new anti-atopic agent. (4).--Anti-inflammatory activity of N-5' (author's transl)]. Nihon Yakurigaku Zasshi 74 : 473-481, 1978 https://doi.org/10.1254/fpj.74.473
  22. Nie L, Mogami H, Kanzaki M, Shibata H, Kojima I : Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells. Mol Pharmacol 50 : 763-769, 1996
  23. Parry PV, Engh JA : Promotion of neuronal recovery following experimental SCI via direct inhibition of glial scar formation. Neurosurgery 70 : N10-N11, 2012
  24. Sharma A : Pharmacological management of acute spinal cord injury. J Assoc Physicians India 60 Suppl : 13-18, 2012
  25. Silver J, Miller JH : Regeneration beyond the glial scar. Nat Rev Neurosci 5 : 146-156, 2004 https://doi.org/10.1038/nrn1326
  26. Spiecker M, Lorenz I, Marx N, Darius H : Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells. Mol Pharmacol 62 : 856-863, 2002 https://doi.org/10.1124/mol.62.4.856
  27. Suzawa H, Kikuchi S, Ichikawa K, Arai N, Tazawa S, Tsuchiya O, et al. : [Effect of tranilast, an anti-allergic drug, on the human keloid tissues]. Nihon Yakurigaku Zasshi 99 : 231-239, 1992 https://doi.org/10.1254/fpj.99.231
  28. Tanaka K, Honda M, Kuramochi T, Morioka S : Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells. Atherosclerosis 107 : 179-185, 1994 https://doi.org/10.1016/0021-9150(94)90019-1
  29. Yan P, Xu J, Li Q, Chen S, Kim GM, Hsu CY, et al. : Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats. J Neurosci 19 : 9355-9363, 1999 https://doi.org/10.1523/JNEUROSCI.19-21-09355.1999
  30. Yang P, He X, Qu J, Li H, Lan B, Yuan P, Wang G : [Expression of nestin and glial fibrillary acidic protein in injured spinal cord of adult rats at different time]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19 : 411-415, 2005
  31. Yin Y, Sun W, Li Z, Zhang B, Cui H, Deng L, et al. : Effects of combining methylprednisolone with rolipram on functional recovery in adult rats following spinal cord injury. Neurochem Int 62 : 903-912, 2013 https://doi.org/10.1016/j.neuint.2013.03.005
  32. Young W : Spinal cord regeneration. Cell Transplant 23 : 573-611, 2014 https://doi.org/10.3727/096368914X678427

Cited by

  1. Ferulic Acid Improves Functional Recovery after Acute Spinal Cord Injury in Rats by Inducing Hypoxia to Inhibit microRNA-590 and Elevate Vascular Endothelial Growth Factor Expressions vol.10, pp.None, 2016, https://doi.org/10.3389/fnmol.2017.00183
  2. Tranilast Treatment Attenuates Cerebral Ischemia‐Reperfusion Injury in Rats Through the Inhibition of Inflammatory Responses Mediated by NF ‐κB and PPAR s vol.12, pp.2, 2016, https://doi.org/10.1111/cts.12606
  3. Effects of methylprednisolone and treadmill training on spinal cord injury in experimental rats vol.22, pp.6, 2021, https://doi.org/10.3892/etm.2021.10849
  4. TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury vol.19, pp.1, 2021, https://doi.org/10.1186/s12951-020-00766-4
  5. Development of a New Formulation Based on In Situ Photopolymerized Polymer for the Treatment of Spinal Cord Injury vol.13, pp.24, 2021, https://doi.org/10.3390/polym13244274